Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Maintains Overweight on Avantor, Raises Price Target to $51

Keybanc analyst Paul Knight maintains Avantor (NYSE:AVTR) with a Overweight and raises the price target from $45 to $51.

byBenzinga Newsdesk

September 9, 2021

1 minute read

Keybanc analyst Paul Knight maintains Avantor (NYSE:AVTR) with a Overweight and raises the price target from $45 to $51.

Ameresco Secures 10-MW Slemon Park Microgrid Project

By Akanksha Bakshi

Today, 8:33 AM

Ameresco Inc (NYSE:AMRC) has secured the Slemon Park Microgrid project, which it will develop in collaboration with Prince Edward Island (PEI)…

AMRC

Barclays Maintains Overweight on AZEK Co, Lowers Price Target to $28

By Benzinga Newsdesk

Today, 8:33 AM

Barclays analyst Matthew Bouley maintains AZEK Co (NYSE:AZEK) with a Overweight and lowers the price target from $29 to $28.

AZEK

Jefferies Maintains Buy on Fair Isaac, Raises Price Target to $745

By Benzinga Newsdesk

Today, 8:33 AM

Jefferies analyst Surinder Thind maintains Fair Isaac (NYSE:FICO) with a Buy and raises the price target from $715 to $745.

FICO

BIMI International Medical Inc. FY21 Sales $27.08M, Up From $12.84M YoY

By Bill Haddad

Today, 8:33 AM

BIMI International Medical Inc. (NASDAQ:BIMI) (“BIMI” or the “Company”), a healthcare products and services provider, today announced its financial results for the fiscal year ended December 31,

BIMI

Keybanc Maintains Overweight on Avantor, Raises Price Target to $51

Related Posts

Ameresco Secures 10-MW Slemon Park Microgrid Project

Barclays Maintains Overweight on AZEK Co, Lowers Price Target to $28

Jefferies Maintains Buy on Fair Isaac, Raises Price Target to $745

BIMI International Medical Inc. FY21 Sales $27.08M, Up From $12.84M YoY